These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1526796)

  • 1. The risks and benefits of intravenous amrinone therapy.
    Haddad A
    Home Healthc Nurse; 1992; 10(5):17-8, 70. PubMed ID: 1526796
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous amrinone therapy: nursing implications.
    Fabius DB; Rein A
    Dimens Crit Care Nurs; 1990; 9(6):336-42. PubMed ID: 2226115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous amrinone therapy at home for the patient with chronic congestive heart failure.
    Moore J
    Focus Crit Care; 1988 Dec; 15(6):32-7. PubMed ID: 3203787
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodynamic effects of amrinone infusion in patients with chronic heart failure.
    Manoharan S; Yadav BS; Tyagi S; Rao DK; Puri YK; Singh PP; Lochan R; Khalilullah M
    Indian Heart J; 1986; 38(5):362-6. PubMed ID: 3570319
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH; Raw K; Patel J; Mitha A; Sareli P
    Am J Cardiol; 1990 Nov; 66(15):1107-12. PubMed ID: 2220638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of intravenous perfusion of amrinone in increasing doses in 12 patients with severe heart decompensation].
    Hagemeijer F; t'Hart C; van Mechelen R; Schelling A
    Rev Med Interne; 1987; 8(2):223-9. PubMed ID: 3589216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent intravenous amrinone infusion: a potentially cost effective mode of treatment of patients with refractory heart failure.
    Levinoff Roth SN; Moe G
    Can J Cardiol; 1993 Apr; 9(3):231-7. PubMed ID: 8508332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous amrinone in the short-term management of refractory heart failure in pregnancy.
    Jelsema RD; Bhatia RK; Ganguly S
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):935-6. PubMed ID: 1923233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic changes caused by a single intravenous dose of amrinone in congestive heart failure].
    Zhi G
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Aug; 17(4):218-20. PubMed ID: 2560706
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home intermittent amrinone infusions in terminal congestive heart failure.
    Baptista RJ; Mitrano FP; Perri-LaFrancesca J
    DICP; 1989 Jan; 23(1):59-62. PubMed ID: 2718486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effects of the infusion of dobutamine and amrinone in patients with refractory cardiac insufficiency].
    Corbalán R; Martínez A; Illanes G; Jalil J; Chamorro G; Casanegra P
    Rev Med Chil; 1987 Dec; 115(12):1130-8. PubMed ID: 3332922
    [No Abstract]   [Full Text] [Related]  

  • 14. Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone.
    Mattingly PM; Burnette PK; Weston MW; Manny RP
    DICP; 1990 Dec; 24(12):1172-4. PubMed ID: 2089824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hemodynamic profile of the response to amrinone treatment in severe heart failure].
    Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A
    Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amrinone in the treatment of severe cardiac insufficiency].
    Suárez LD; Reader C; Guevara E; Delisio HJ
    Medicina (B Aires); 1985; 45(5):517-21. PubMed ID: 3916118
    [No Abstract]   [Full Text] [Related]  

  • 17. Long term survival of class IV heart failure patients treated with oral amrinone.
    Moran JF; Rad N; Scanlon PJ
    J Clin Pharmacol; 1989 Jun; 29(6):494-9. PubMed ID: 2754019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of amrinone in refractory cardiac insufficiency: clinical and hemodynamic evaluation].
    Massari FM; De Martini M; Foresti A; Valentini R; Bertoni T; Lotto A
    G Ital Cardiol; 1986 Oct; 16(10):845-54. PubMed ID: 3817367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amrinone in acute severe cardiac failure.
    Heuer H; Frenking B; Gülker H
    Arzneimittelforschung; 1988 Apr; 38(4):567-70. PubMed ID: 3401270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of long-term amrinone therapy in patients with congestive heart failure: a placebo controlled trial.
    Rettig G; Sen S; Fröhlig G; Schieffer H; Bette L
    Eur Heart J; 1986 Jul; 7(7):628-31. PubMed ID: 3530768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.